SG Americas Securities
CNST

SG Americas Securities’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

SG Americas Securities’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,940
Closed -$809K – 3950
2021
Q2 		$809K Sell
23,940
-45,833
-66% -$1.17M ﹤0.01% 1688
2021
Q1 		$1.63M Buy
69,773
+4,579
+7% +$139K 0.01% 1188
2020
Q4 		$1.88M Sell
65,194
-41,568
-39% -$1.05M 0.01% 1130
2020
Q3 		$2.16M Buy
106,762
+86,621
+430% +$2.11M 0.01% 695
2020
Q2 		$605K Buy
20,141
+13,534
+205% +$487K 0.01% 1908
2020
Q1 		$208K Buy
+6,607
New +$230K ﹤0.01% 2473

SG Americas Securities's CNST Position: Q3 2021 in Review

SG Americas Securities sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 23,940 shares — an estimated $809K sold.

SG Americas Securities first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $2.16M in Q3 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • SG Americas Securities reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • SG Americas Securities sold 23,940 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $809K.
  • SG Americas Securities first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
  • SG Americas Securities's Constellation Pharmaceuticals, Inc. position peaked at $2.16M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on SG Americas Securities's 13F filing for Q3 2021, filed 1 Nov 2021.